Use of haemoglobin adducts in exposure monitoring and risk assessment

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 778, Issue 1-2, 2002, Pages 309-322

  Boogaard, Peter J ^a  

^a SHELL GLOBAL SOLUTIONS INTERNATIONAL B V   (United States)

Author keywords

Exposure monitoring; Haemoglobin adducts; Risk assessment

Indexed keywords

BUTADIENE; DEGRADATION; ETHYLENE; INDUSTRIAL CHEMICALS; MASS SPECTROMETRY; OXIDES; PROPYLENE; RISK ASSESSMENT;

BIOLOGICAL MONITORING;

HEMOGLOBIN;

1,3 BUTADIENE; ALKENE; DNA; ETHYLENE OXIDE DERIVATIVE; GLOBIN; HEMOGLOBIN; INDUSTRIAL CHEMICAL; N (2 HYDROXYETHYL)VALINE; PROPYLENE OXIDE; UNCLASSIFIED DRUG; VALINE;

AIR MONITORING; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ASSAY; BIOLOGICAL MONITORING; CALCULATION; CALIBRATION; CARCINOGENICITY; CHEMICAL STRUCTURE; CORRELATION ANALYSIS; DEGRADATION; ENVIRONMENTAL EXPOSURE; GAS CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INDUSTRIAL WORKER; MAMMAL; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MUTAGENICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; POPULATION AND POPULATION RELATED PHENOMENA; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; RODENT; STANDARD; TOXICOLOGY;

ENVIRONMENTAL EXPOSURE; HEMOGLOBINS; HUMANS; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT;

MAMMALIA; RODENTIA;

EID: 0037027006     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(01)00445-5     Document Type: Review

References (93)

1. Törnqvist M., Kautiainen A., Gatz R.N., Ehrenberg L. J. Appl. Toxicol. 8:1988;159.
2. Törnqvist M., Gustafsson B., Kautiainen A., Harms-Ringdahl M., Granath F., Ehrenberg L. Carcinogenesis. 10:1989;39.
3. Kautiainen A., Törnqvist M. Int. Arch. Occup. Environ. Health. 63:1991;27.
4. Richardson K.A., Megens H.J.J.J., Webb J.D., van Sittert N.J. Toxicology. 113:1996;112.
5. Richardson K.A., Peters M.M.C.G., Wong B.A., Megens H.J.J.J., van Elburg P.A., Booth E.D., Boogaard P.J., Bond J.A., Medinsky M.A., Watson W.P., van Sittert N.J. Toxicol. Sci. 49:1999;186.
6. van Sittert N.J., Megens H.J.J.J., Watson W.P., Boogaard P.J. Toxicol. Sci. 56:2000;189.
7. Walker V.E., Wu K.-Y., Upton P.B., Ranasinghe A., Scheller N., Cho M.-H., Vergnes J.S., Skopek T.R., Swenberg J.A. Carcinogenesis. 21:2000;1661.
8. NTP, Technical Report Series No. 326. NIH Publication No. 88-2582., Research Triangle Park, NC, and Bethesda, MD, 1987.
9. IARC, Ethylene Oxide, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 60 (1994) 73.
10. ®. Threshold limit values for chemical substances and physical agents. Biological exposure indices. American Conference of Governmental Industrial Hygienists, Cincinnati, OH, USA, 2001.
11. van Sittert N.J., Boogaard P.J., Natarajan A.T., Tates A.D., Ehrenberg L., Törnqvist M.A. Mutat. Res. 447:2000;27.
12. Tates A.D., van Dam F.J., Natarajan A.T., van Teylingen C.M.M., de Zwart F.A., Zwinderman A.H., van Sittert N.J., Nilsen A., Nilsen O.G., Zahlsen K., Magnusson A.-L., Törnqvist M. Mutat. Res. 431:1999;397.
13. NTP, National Technical Information Service, NTP Technical report Series number 267, Springfield, VA, USA, 1985.
14. ACTS, Propylene Oxide. Criteria Document for an occupational exposure limit (draft, report number ACTS/33/92, Advisory Committee on Toxic Substances, UK Health and Safety Executive, Bootle, Merseyside, UK, 1992.
15. IARC, Propylene Oxide, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 60 (1994) 181.
16. Ehrenberg L., Hussain S. Mutat. Res. 86:1981;1.
17. Pauwels W., Veulemans H. Mutat. Res. 418:1998;21.
18. Ríos-Blanco M.N., Plna K., Faller T., Kessler W., Håkansson K., Kreuzer P.E., Ranasinghe A., Filser J.G., Segerbäck D., Swenberg J.A. Mutat. Res. 380:1997;179.
19. Farooqi Z., Törnqvist M., Ehrenberg L., Natarajan A.T. Mutat. Res. 288:1993;223.
20. Vogel E.W., Nivard M.J.M. Environ. Mol. Mutagenesis. 29:1997;124.
21. IARC, Ethylene, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 60 (1994) 45.
22. IARC, Propylene, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 60 (1994) 161.
23. IARC, 1,3-Butadiene, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 71 (1999) 109.
24. Himmelstein M.W., Acquavella J.F., Recio L., Medinsky M.A., Bond J.A. Crit. Rev. Toxicol. 27:1997;1.
25. van Welie R.T.H., van Dijck R.G.J.M., Vermeulen N.P.E., van Sittert N.J. Crit. Res. Toxicol. 22:1992;271.
26. Timbrell J.A., Draper R., Waterfield C.J. Biomarkers. 1:1996;1.
27. Osterman-Golkar S., Ehrenberg L., Segerbäck D., Hällström I. Mutat. Res. 34:1976;1.
28. Calleman C.J., Ehrenberg L., Jansson B., Osterman-Golkar S., Segerbäck D., Svensson K., Wachtmeister C.A. J. Environ. Pathol. Toxicol. 2:1978;427.
29. Osterman-Golkar S., Bailey E., Farmer P.B., Gorf S.M., Lamb J.H. Scand. J. Work Environ. Health. 10:1984;99.
30. Wraith M.J., Watson W.P., Eadsforth C.V., van Sittert N.J., Törnqvist M., Wright A.S. IARC Sci. Publ. 89:1988;271.
31. Törnqvist M., Mowrer J., Jensen S., Ehrenberg L. Anal. Biochem. 154:1986;255.
32. Jensen S., Törnqvist M., Ehrenberg L. de Serres F.J., Pero R.W., Individual Susceptibility to Genotoxic Agents in the Human Population. Environmental Science Research. Vol. 30:1984;315 Plenum, New York.
33. Osterman-Golkar S., Kautiainen A., Bergmark E., Håkansson K., Määki-Paakkanen J. Chem.-Biol. Interact. 80:1991;291.
34. Albrecht O.E., Filser J.G., Neumann H.G. IARC Sci. Publ. 127:1993;135.
35. Tates A.D., Boogaard P.J., Darroudi F., Natarajan A.T., van Sittert N.J. Mutat. Res. 329:1995;63.
36. Ríos-Blanco M.N., Faller T.H., Nakamura J., Kessler W., Kreuzer P.E., Ranasinghe A., Filser J.G., Swenberg J.A. Carcinogenesis. 21:2000;2011.
37. Granath F., Ehrenberg L., Törnqvist M. Mutat. Res. 284:1992;297.
38. Fennell T.R., Sumner S.C.J., Walker V.E. Cancer Epidemiol. Biomarkers Prev. 1:1992;213.
39. ECETOC. DNA and protein adducts: evaluation of their use in exposure monitoring and risk assessment. Monograph No. 13, Brussels, 1989.
40. Ehrenberg L., Granath F., Törnqvist M. Environ. Health Perspect. 104:1996;423.
41. van Sittert N.J., van Vliet E.W.N. Clin. Chem. 40:1994;1472.
42. Boogaard P.J., Rocchi P.S.J., van Sittert N.J. Int. Arch. Occup. Environ. Health. 72:1999;142.
43. van Sittert N.J., Beulink G.D.J., van Vliet E.W.N., van der Waal H. Environ. Health Perspect. 99:1993;217.
44. 3M Organic vapour monitors sampling and analysis guide. 3M, Minneapolis, MN, USA, 1986.
45. NIOSH, Manual of Analytical Methods. 3rd ed. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Cincinnati, OH, USA, 1985.
46. A. Bianchi, B. Boyle, P. Harrison, P. Lawrie, T. Le Lendu, P. Rocchi, R. Taalman, and W. Wieder, A review of analytical methods and their significance to subsequent occupational exposure data evaluation for 1,3-butadiene. CEFIC, Brussels/IISRP, London, UK, 1997.
47. Albertini R.J., Šrám S.R., Vacek P.M., Lynch J., Wright M., Nicklas J.A., Boogaard P.J., Henderson R.F., Swenberg J.A., Tates A.D., Ward J.B. Chem.-Biol. Interact. 135-136:2001;429.
48. Svensson K., Olofsson K., Osterman-Golkar S. Chem.-Biol. Interact. 78:1991;55.
49. Mowrer J., Törnqvist M., Jensen S., Ehrenberg L. Toxicol. Environ. Chem. 11:1986;215.
50. Boogaard P.J., van Sittert N.J., Megens H.J.J.J. Chem.-Biol. Interact. 135-136:2001;695.
51. Törnqvist M., Magnusso A.L., Farmer P.B., Tang Y.S., Jeffrey A.M., Wazneh L., Beulink G.D., van der Waal H., van Sittert N.J. Anal. Biochem. 203:1992;357.
52. Thulin H., Zorcec V., Segerbäck D., Sundwall A., Törnqvist M. Chem.-Biol. Interact. 99:1996;263.
53. Hindsø Landin H., Osterman-Golkar S., Zorcec V., Törnqvist M. Anal. Biochem. 240:1996;1.
54. Hindsø Landin H., Tareke E., Rydberg P., Olsson U., Törnqvist M. Fd. Chem. Toxicol. 38:2000;963.
55. Kautiainen A., Törnqvist M., Svensson K., Osterman-Golkar S. Carcinogenesis. 10:1989;2123.
56. Kautiainen A. Chem.-Biol. Interact. 83:1992;55.
57. Thier J., Lewalter J., Kempkes M., Selinski S., Brüning T., Bolt H.M. Arch. Toxicol. 73:1999;197.
58. Bergmark E., Calleman C.J., He F., Costa L.G. Toxicol. Appl. Pharmacol. 120:1993;45.
59. Tareke E., Golding B.T., Small R.D., Törnqvist M. Xenobiotica. 28:1998;663.
60. Törnqvist M.Å., Almberg J.G., Bergmark E.N., Nilsson S., Osterman-Golkar S. Scand. J. Work Environ. Health. 15:1989;436.
61. Eide I., Hagemann R., Zahlsen K., Tareke E., Törnqvist M., Kumar R., Vodicka P., Hemminki K. Carcinogenesis. 16:1995;1603.
62. Pérez H.L., Lähdetie J., Hindsø-Landin H., Kilpeläinen I., Koivisto P., Peltonen K., Osterman-Golkar S. Chem.-Biol. Interact. 105:1997;181.
63. Hayes R.B., Zhang L., Yin S., Swenberg J.A., Xi L., Wiencke J., Bechtold W.E., Yao M., Rothman N., Haas R., O'Neill J.P., Zhang D., Wiemels J., Dosemeci M., Li G., Smith M.T. Carcinogenesis. 21:2000;55.
64. Rydberg, Magnusson A.L., Zorcec V., Granath F., Törnqvist M. Chem. Biol. Interact. 101:1996;193.
65. Kautiainen A., Fred C., Rydberg P., Törnqvist M. Rapid Commun. Mass Spectrom. 14:2000;1848.
66. Swenberg J.A., Koc H., Upton P.B., Georguieva N., Ranasinghe A., Walker V.E., Henderson R. Chem.-Biol. Interact. 387:2001;135.
67. Törnqvist M., Osterman-Golkar S., Kautiainen A., Jensen S., Farmer P.B., Ehrenberg L. Carcinogenesis. 7:1986;1519.
68. Bailey E., Brooks A.G.F., Dollery C.T., Farmer P.B., Passingham B.J., Sleightholm M.A., Yates D.W. Arch. Toxicol. 62:1988;247.
69. Sarto F., Törnqvist M., Tomanin R., Bartolucci G.B., Osterman-Golkar S., Ehrenberg L. Scand. J. Work Environ. Health. 17:1991;60.
70. Bader M., Lewalter J., Angerer J. Int. Arch. Occup. Environ. Health. 67:1995;237.
71. Segerbäck D., Calleman C.J., Ehrenberg L., Lofröth G., Osterman-Golkar S. Mutat. Res. 49:1978;71.
72. Potter D., Blair D., Davies R., Watson W.P., Wright A.S. Arch. Toxicol. Suppl. 13:1989;254.
73. Walker V.E., Fennell T.R., Upton P.B., MacNeela J.P., Swenberg J.A. Environ. Health Perspect. 99:1993;11.
74. Koivisto P., Adler I.-D., Pacchierotti F., Peltonen K. Mutat. Res. 397:1998;3.
75. Tates A.D., Boogaard P.J., Darroudi F., Natarajan A.T., Caubo M.E., van Sittert N.J. Mutat. Res. 329:1995;63.
76. Fost U., Törnqvist M., Leutbecher M., Granath F., Hallier E., Ehrenberg L. Human Exp. Toxicol. 14:1995;201.
77. Ehrenberg L., Moustacchi E., Osterman-Golkar S., Ekman G. Mutat. Res. 123:1983;121.
78. Watson W.P., van Sittert N.J. Trans. Ind. Chem. Eng. 73:1995;S28.
79. Ehrenberg L. Acta Biol. Yugosl. Genet. 6:1974;367.
80. Wright A.S., Bradshaw T.K., Watson W.P. IARC Sci. Publ. 89:1988;237.
81. Ehrenberg L. IARC Sci. Publ. 89:1988;23.
82. Hogstedt L.C. IARC Sci. Publ. 89:1988;265.
83. Granath F.N., Vaca C.E., Ehrenberg L.G., Törnqvist M.A. Risk Anal. 19:1999;309.
84. Csanády Gy.A., Denk B., Pütz C., Kreuzer P.E., Kessler W., Baur C., Gargas M.L., Filser J.G. Toxicol. Appl. Pharmacol. 165:2000;1.
85. Duus U., Osterman-Golkar S., Törnqvist M., Mowrer J., Holm S., Ehrenberg L. Freij L., Proceedings of the Symposium on Management of risk from genotoxic substances in the environment. Swedish National Chemicals Inspectorate, Solna, Sweden, 1989, p. 141.
86. Osterman-Golkar S., Bond J.A. Environ. Health Perspect. 104:(Suppl. 5):1996;907.
87. DFG. Maximale Arbeitsplatzkonzentrationen und biologische Arbeitsstoff Toleranzwerte 1997. Mitteilung XXXIII der Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. VCH Verlaggesellschaft mbH, Weinheim, Germany, 1997.
88. Angerer J., Bader M., Krämer A. Int. Arch. Occup. Environ. Health. 71:1998;14.
89. van Sittert N.J. Angerer J., Schaller K.H., Analyses of Hazardous Substances in Biological Materials. Vol. 5:1979;181 VCH, Weinheim, Germany.
90. Högstedt B., Bergmark E., Törnqvist M., Osterman-Golkar S. Hereditas. 113:1990;133.
91. Osterman-Golkar S., Bond J.A., Ward J.B., Legator M.S. IARC Sci. Publ. 127:1993;127.
92. R.L. Ball, The development of class-specific and compound specific antibodies for the detection, identification and exposure monitoring of genotoxic carcinogens, Ph.D. Thesis, Univ. Edinburgh, 1996.
93. Ball R.L., Aston J.P., Pople J. Proceedings of the 26th International Congress on Occupational Health, Singapore, 2000, p. 311.